Azienda Ospedaliera Universitaria Integrata Verona
Clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, explained in plain language.
-
Breast cancer drug repurposed for cystic fibrosis in groundbreaking trial
Disease control Not yet recruitingThis study is testing whether tamoxifen, a drug used for breast cancer, is safe and tolerable for adults with cystic fibrosis who have genetic mutations that make them ineligible for current targeted CFTR modulator drugs. Thirty-five participants will take tamoxifen daily for six…
Phase: PHASE2 • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New stent placement method tested to keep bile ducts open longer
Disease control Not yet recruitingThis study is testing two different ways to place plastic tubes (stents) to open blocked bile ducts in patients with cancer. The goal is to see if placing the stent above a certain valve (suprapapillary) works better and lasts longer than the standard method that goes through the…
Phase: NA • Sponsor: Azienda Ospedaliera Universitaria Integrata Verona • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC